Neoleukin Therapeutics, Inc.

Historical 13F Holders

Symbol
NLTX
CUSIP
64049K104
All holders as of
Q2 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q2 40 17.4 M $14.4 M
2023 Q1 41 15.1 M $10.5 M
2022 Q4 48 17.1 M $8.73 M
2022 Q3 53 18.7 M $12.0 M
2022 Q2 69 20.8 M $21.4 M
2022 Q1 85 24.6 M $49.7 M
2021 Q4 90 24.7 M $119 M
2021 Q3 89 25.9 M $187 M
2021 Q2 88 27.0 M $249 M
2021 Q1 88 27.8 M $342 M
2020 Q4 94 28.0 M $394 M
2020 Q3 87 27.6 M $331 M
2020 Q2 78 25.1 M $417 M
2020 Q1 64 22.7 M $259 M
2019 Q4 60 19.9 M $245 M
2019 Q3 37 18.8 M $53.7 M